SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000040
Filing Date
2024-04-17
Accepted
2024-04-16 21:27:40
Documents
9
Period of Report
2024-04-16

Document Format Files

Seq Description Document Type Size
1 6-K form6-kxpressreleasecoverf.htm 6-K 20689
2 EX-99.1 exhibit991appendix2a-app.htm EX-99.1 7932
3 exhibit991appendix2a-app001.jpg GRAPHIC 78154
4 exhibit991appendix2a-app002.jpg GRAPHIC 62330
5 exhibit991appendix2a-app003.jpg GRAPHIC 58556
6 exhibit991appendix2a-app004.jpg GRAPHIC 118514
7 exhibit991appendix2a-app005.jpg GRAPHIC 77006
8 exhibit991appendix2a-app006.jpg GRAPHIC 98222
9 exhibit991appendix2a-app007.jpg GRAPHIC 55385
  Complete submission text file 0001345099-24-000040.txt   785163
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 24849224
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)